Objectives: There is growing evidence to suggest that biofilms may be involved in the aetiology of chronic wounds. The development of formulations with enhanced anti-biofilm activity could therefore represent a potential therapeutic strategy by reducing bioburdens. Here, the antimicrobial properties of ionic silver and sodium hexametaphosphate (polyphosphate) against bacteria in planktonic form and as biofilms were investigated.
Introduction
Chronic wounds are characterized by prolonged inflammation and delayed healing, which are associated with diminished neovascularization and re-epithelization. 1 Impaired wound healing has been correlated with numerous host factors, including nutritional status, 2 metabolic diseases, 3 radiation exposure 4 and smoking. 5 Importantly, chronic wounds are frequently colonized by a consortium of bacteria, which may include Staphylococcus aureus and Pseudomonas aeruginosa, obligate anaerobes, such as Finegoldia spp., 6 as well as filamentous fungi and yeasts, such as Candida spp. 7 Microbial structures imaged in chronic wound tissue biopsies, together with recalcitrance to antimicrobial treatments, suggests that the associated bacteria may form biofilms, 8 which have been defined as aggregates of microorganisms attached to a substratum and encased within a self-produced layer of extracellular polymeric substance. 9 The biofilm phenotype confers protection from antimicrobial therapy and reportedly also to host immune factors, potentially leading to prolonged hyper-inflammation and failure to heal through the constant expression of antigens at the wound bed. 10, 11 Novel therapeutic treatments are increasingly sought for the management of chronic wounds. 12 Traditionally, tissue debridement and antibiotic administration have been utilized in combination, with the aim of promoting healing and reducing tissue bioburdens. Topical hydrogels, hydrocolloids and polyurethane films have also been utilized to promote the autolytic debridement of devitalized tissue while moistening dry and moderately exuding wounds. 13 Additionally, hydrogels can be used to immobilize and deliver antimicrobials directly to the wound bed.
Ionic silver achieves bacteriostatic activity at concentrations as low as 30 mg/L. 14 While polyphosphates are generally less potent antimicrobially, they have been considered for use as preservation agents for meat and dairy products. Sodium hexametaphosphate (polyphosphate), for example, is bacteriostatic towards microorganisms, including P. aeruginosa, S. aureus, Salmonella typhimurium and Clostridium spp., at concentrations commonly used by the food industry (2000 -8000 mg/L). 15 -17 To date, the bactericidal properties of polyphosphate have not been evaluated for the management of bacteria associated with chronic wounds, however, this compound has been shown to promote blood clotting in a murine study. 18 Due to the purported importance of biofilms in the aetiology of chronic wounds, antibacterial treatment agents should ideally exhibit anti-biofilm potency, and several in vitro model systems have been developed for the preclinical testing of this property. 19 The CDC biofilm reactor is one such system, based on a continuous culture vessel into which substrata are suspended, allowing the generation of replicated biofilms upon coupons, under conditions of controlled shear force and nutrient availability. 20 Statistical analyses of P. aeruginosa biofilms generated in the CDC biofilm reactor have shown it to be highly reproducible and relatively insensitive to minor changes in nutrient concentration, shear force and temperature. 21 The CDC reactor has previously been utilized to investigate bacterial (Proteus mirabilis and Staphylococcus epidermidis) and fungal (Candida spp.) biofilms, 22 -24 as well as for the optimization of P. aeruginosa and S. aureus anti-biofilm strategies under defined fluid shear conditions. 25 In the current investigation, the antimicrobial activity of candidate wound care hydrogels, supplemented with ionic silver and polyphosphate, singly or in combination, was investigated. In order to determine the relative susceptibility of the test microorganisms to the active agents, MICs, MBCs and minimum biofilm eradication concentrations (MBECs) were determined for both silver nitrate and polyphosphate for S. aureus, P. aeruginosa and Candida albicans cultures and potential combined effects between polyphosphate and ionic silver were investigated using chequerboard susceptibility analyses. The antimicrobial effects of hydrogel formulations incorporating ionic silver and polyphosphate, singly and in combination, were then evaluated against mature biofilms grown in CDC biofilm reactors.
Methods

Chemicals and growth media
All formulated bacteriological media were obtained from Oxoid Ltd (Basingstoke, Hampshire, UK). Unless otherwise stated, chemicals were obtained from Sigma (Poole, Dorset, UK). Bacteriological media and solutions were sterilized by autoclaving at 1218C for 20 min (1 kg/cm 2 ). The hydrogels were supplied by Advanced Medical Solutions (Winsford, Cheshire, UK).
Test strains and culture conditions
The bacteria used in this study were S. aureus ATCC 6538, C. albicans ATCC 10231 and P. aeruginosa ATCC 9027. These were purchased from Oxoid Ltd (Basingstoke, Hampshire, UK).
Antimicrobial actives and hydrogels
Stock solutions of ionic silver (80 000 mg/L) and polyphosphate (320000 mg/L) were prepared from silver nitrate (AgNO 3 ) and sodium hexametaphosphate (polyphosphate; NaPO 3 ) 6 by dissolving in distilled water. Stock solutions (0.2 mM) were filter-sterilized (0.22 mm; Millipore, Watford, UK). Six hydrogel formulations were tested, which contained the following concentrations of silver sulphate and sodium hexametaphosphate: (i) 2% polyphosphate; (ii) 4% polyphosphate; (iii) 0.4% silver; (iv) 0.4% silver combined with 2% polyphosphate; (v) 0.4% silver combined with 4% polyphosphate; and (vi) 0.6% silver combined with 4% polyphosphate. A non-antimicrobial hydrogel (ActivHeal; AMS, Winsford, UK) was included as a negative control.
Determinations of bacterial susceptibility
The MIC for each antimicrobial was determined using the microdilution method. 26 Briefly, aliquots of overnight bacterial cultures were diluted 1 in 100 in tryptone soya broth in a 96-well microtitre plate containing 2-fold dilutions of either polyphosphate (320 000 mg/L to 30 mg/L) or silver nitrate (80 000 mg/L to 9 mg/L) along the ordinate. Plates were incubated at 378C (12 h). The MIC was defined as the lowest concentration of antimicrobial to prevent bacterial growth. Culture fluid from wells (10 mL) showing no visual signs of turbidity were transferred to aliquots of fresh tryptone soya broth and incubated for a further 12 h (378C) for the determination of the MBC (defined as the lowest concentration required to kill the inoculum in a given time). MBECs (the concentration required to completely inactivate the test biofilms in a given time) were determined using the NUNC-TSP transferable solid phase screening system (NUNC, Roskilde, Denmark), as described previously. 27 
Analysis of combinatorial activity
Potential combinatorial activity between polyphosphate and silver nitrate was evaluated using the chequerboard synergy methodology against planktonic cultures and biofilms, as previously described. 28 For this, 2-fold dilutions of polyphosphate were prepared in duplicate in 96-well plates (NUNC, Roskilde, Denmark) along the ordinate so that the final concentration of polyphosphate ranged from one-tenth to four times the MIC. Similarly, concentrations of silver nitrate were prepared as 2-fold dilutions along the abscissa ranging from one-tenth of the MIC value at the bottom of the microtitre plate to four times the MIC at the top. Plates were then inoculated with overnight cultures of bacteria (1 mL). Plates were incubated at 378C for 14 h with agitation (110 rpm). The fractional inhibitory concentration index (FICI) was then used to determine the combined activity of each antimicrobial as follows: The fractional inhibitory concentration (FIC) of polyphosphate was determined by dividing the MIC in combination with silver nitrate by the MIC of the polyphosphate alone. The FIC for silver nitrate was determined by dividing the MIC of silver nitrate in combination with polyphosphate by the MIC of silver nitrate alone. The addition of FIC values for both polyphosphate and silver generated the FICI, which was defined as indifference (,0.5), synergy (0.5-4.0) or antagonism (.4.0). 28 -30 The combinatorial anti-biofilm activity of polyphosphate and silver nitrate was determined following the exposure of biofilms cultured using the NUNC-TSP transferable solid phase screening system (72 h; 378C). Biofilms were exposed to combinations of polyphosphate and silver nitrate for 18 h. Transferable peg lids were washed three times in sterile water and transferred to sterile tryptone soya broth for sonication as described previously 31 (5 min; Soniprep 150, MSE UK Limited, London, UK) and incubated (18 h; 378C) for the determination of relative MBEC values. Combinatorial activity against biofilms was determined using an adaption of the FICI (referred to as the fractional biofilm eradication concentration index; FBCI). The fractional biofilm eradication concentration (FBC) for polyphosphate was calculated by dividing the MBEC in combination with silver nitrate by the MBEC of the polyphosphate alone. The FBC for silver nitrate was determined by dividing the MBEC of silver nitrate in combination with polyphosphate by the MBEC of silver nitrate alone. The addition of FBC values for both polyphosphate and silver generated the FBCI, which Anti-biofilm activities of silver and sodium hexametaphosphate 2557 JAC was defined as indifference (,0.5), synergy (0.5 -4.0) or antagonism (.4.0).
Evaluation of the anti-biofilm potency of hydrogel formulations
Biofilms were established within CDC biofilm reactors (BioSurface Technologies Corp; Bozeman, MT, USA), which comprise glass vessels into which polypropylene rods (n¼8), each housing three circular polycarbonate biofilm coupons, 12.7 mm in diameter, were suspended in sterile tryptone soya broth (400 mL) overnight at room temperature. Following this, biofilm reactors were inoculated with aliquots of mid-log phase culture of each test strain (1 mL; OD 1.5 at 660 nm). The reactors were maintained under batch culture conditions for 8 h at 378C to promote bacterial attachment and biofilm formation upon the polycarbonate coupons (the magnetic baffle bar was set to 125 rpm throughout). Following this, the biofilm reactors were maintained under continuous culture conditions (medium flow rate 10 cm 3 /h) for 72 h to maximize nutrient availability and promote biofilm formation.
Exposure of biofilms to hydrogel formulations
Colonized coupons were aseptically removed from the biofilm reactors and transferred to sterile 12-well Corning Costar TM cell culture plates (Sigma-Aldrich, Dorset, UK) containing the test hydrogels (3 mL). Biofilms were exposed in this manner for periods of 2, 8 and 24 h at 378C. On sampling, the coupons were transferred to neutralization buffer (10 mL; 0.1% Na 2 S 2 O 3 /1 M CaCl 2 in dH 2 0) supplemented with glass beads (0.1 g) and agitated using a vortex mixer to remove attached bacteria.
The resulting bacterial suspensions were serially diluted and selected dilutions plated in triplicate onto nutrient agar, incubated (18 h; 378C) and colonies were counted.
Statistical analyses
Data in Table 3 were checked for normal distribution using the AndersonDarling test for normality. A paired t-test was then used to compare viable counts before (0 h) and after biocide exposure (2, 8 and 24 h). Statistical analyses were performed using Minitab 15 (Minitab Ltd, Coventry, UK). Table 1 shows MIC and MBC data for polyphosphate and silver nitrate against S. aureus, P. aeruginosa and C. albicans. Based on this analysis, S. aureus was comparatively susceptible to polyphosphate (MIC 940 mg/L), while P. aeruginosa was much less so (MIC 40000 mg/L). Silver nitrate inhibited all bacterial strains at relatively low concentrations (MIC ≤70 mg/L). The comparative recalcitrance of the test bacteria when grown as biofilms is demonstrated by the considerably higher MBEC values for polyphosphate, which were 320000 mg/L against P. aeruginosa and S. aureus and 160 000 mg/L for C. albicans. In contrast, silver nitrate achieved biofilm eradication at concentrations of 7500 mg/L against S. aureus and 40 000 mg/L against both P. aeruginosa and C. albicans (Table 2) . In all cases the FIC refers to the inhibitory value derived for the primary agent when combined with the minimum concentration of the secondary agent. 
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The previously validated FICI 28 and a biofilm-specific adaptation, which generates an FBCI, were used. Putative antimicrobial synergy occurred between silver nitrate and polyphosphate against S. aureus (FICI 0.39) and P. aeruginosa (FICI 0.36), but not against C. albicans (FICI 1.22; Table 1 ). Anti-biofilm synergy was observed however following combined exposure of C. albicans (FBCI 0.06), P. aeruginosa (FBCI 0.08) and S. aureus (FBCI 0.44) to polyphosphate and silver nitrate ( Table 2) .
Exposure of simulated wound biofilms in continuous culture Table 3 shows the anti-biofilm activity of various hydrogel formulations. P. aeruginosa, S. aureus and C. albicans were exposed to ActivHeal hydrogel as a negative control. No significant reductions in viable counts occurred for P. aeruginosa and C. albicans following 24 h exposure to the negative control formulation, although a small but significant reduction in S. aureus viable counts was observed following 24 h (Table 3 ; P ¼ 0.011).
With respect to formulations supplemented with silver sulphate and polyphosphate, hydrogels containing silver alone were considerably more potent than the polyphosphate hydrogels. However, while exposure to the 0.4% w/w ionic silver hydrogel caused significant reductions in microbial viability following only 2 h of exposure, the incorporation of polyphosphate at 2 and 4% enhanced the anti-biofilm effect. A marked effect occurred following a 2 h exposure of S. aureus to hydrogels containing 0.4% w/w silver sulphate and 2% polyphosphate (P,0.05), such that the test organism became undetectable. In addition, all test bacteria became undetectable following 8 h exposure to hydrogels supplemented with 0.4% silver sulphate and 4% polyphosphate (Table 3) .
Discussion
Chronic wounds are characterized by their failure to proceed through the normal healing process, leading to prolonged inflammation. 32 Systemic antibiotics are generally of limited efficacy in the management of such wounds due to their poor perfusion into wound beds and possibly also due to the welldocumented recalcitrance of biofilms to antimicrobials. 33 As Anti-biofilm activities of silver and sodium hexametaphosphate 2559 JAC such, increasing research attention is being directed towards the development of antimicrobial strategies with enhanced antibiofilm potency for the treatment of chronic wounds. The use of ionic silver as a topical antimicrobial is welldocumented, and reportedly achieves broad-spectrum activity and high potency at comparatively low concentrations (30 mg/L). 14, 34, 35 The antimicrobial action of polyphosphate on the other hand has been most commonly exploited by the food industry. 36 Polyphosphates are polymers of orthophosphate residues linked by phosphoanhydride bonds and can form linear structures of various sizes, such as the long chainlength polyphosphates, sodium polyphosphate, glassy structures, or cyclic ring structures, such as sodium hexametaphosphate. Polyphosphates are believed to exhibit their bactericidal activity through a number of mechanisms, including the sequestration of free divalent cations. 15, 16, 37 Maier et al., 37 reported that polyphosphate inhibited cellular septation in Bacillus cereus through interaction with the divalent cationdependent GTPase activity of the cell division protein FtsZ.
Data generated in the current study support some previous reports regarding Gram-positive bacteria, 15, 16 where the bacteriostatic action of polyphosphate towards planktonic cultures of S. aureus was observed at concentrations of 940 mg/L and where ionic silver achieved growth inhibition at concentrations lower than 70 mg/L (Table 1). 14 Polyphosphate did exhibit bactericidal activity, but at significantly higher concentrations (20 000-40000 mg/L) such that ionic effects might have contributed significantly to lethality.
When ionic silver and polyphosphate were applied in combination during chequerboard analyses, putative antimicrobial synergy was observed for P. aeruginosa (FICI 0.36) and S. aureus (FICI 0.39; Table 1 ). Antimicrobial synergy between polyphosphate and hydrophobic antimicrobials such as rifampicin, SDS and the non-ionic surfactant Triton X-100 has been previously reported and was attributed to polyphosphate-mediated changes in the Gram-negative outer membrane. 38 Similarly, in Gram-positive bacteria, the exposure of S. aureus to polyphosphate may result in increased permeability of the cell envelope, which can be detected as nucleotide leakage. 39 Mechanisms by which ionic silver and polyphosphate exhibited synergy were not investigated in the present study, but this may involve the destabilization of membrane-associated divalent cations by polyphosphate leading to increased cellular permeability towards secondary active substances, such as ionic silver. Previously Feng et al. 40 observed that the collection of silver particles in the cytoplasm of S. aureus and Escherichia coli was associated with morphological changes, such as cytoplasmic membrane shrinkage, as well as loss of DNA replication and protein inactivation leading to cell death. It is interesting to note that the degree of morphological change reported by Feng et al. 40 was less marked in Gram-positive bacteria, possibly due to the cell wall retarding silver ion penetration. In the presence of polyphosphate however, the penetration of silver ions may be promoted. Importantly, data in the current investigation also suggest anti-biofilm activity, which was observed following exposure of biofilms of both test bacteria and also for C. albicans (Table 2) . Based on chequerboard susceptibility data, which suggested antimicrobial and anti-biofilm synergy between polyphosphate and ionic silver, mature biofilms were generated using the CDC biofilm reactor and exposed to prototype wound-care hydrogels containing various concentrations of silver sulphate and polyphosphate.
The exposure of biofilms to these hydrogels indicated that, as with MBEC data, ionic silver was more antimicrobially potent than polyphosphate and caused significant reductions in viable counts within 2 h of exposure (Table 3 ). The anti-biofilm effect of polyphosphate was less marked, and the extent of bacterial inactivation did not directly correlate with increased concentration. Indeed, hydrogels containing 2% polyphosphate achieved markedly better cellular inactivation for S. aureus than the 4% formulation, and similarly for C. albicans, following 8 h exposure (Table 3 ). This reproducible observation could be due to formulation effects whereby the active agent was less bioavailable at high concentrations due, for example, to concentration-dependent complexation, or may have a biological cause analogous to paradoxical concentration effects that are occasionally reported for antibiotics. 41 Importantly, however, the addition of polyphosphate to silver-based hydrogels resulted in considerably enhanced anti-biofilm efficacy, with significantly greater reductions in biofilm viability occurring in comparison to hydrogels containing either ionic silver or polyphosphate as the sole active agent.
Exposure of S. aureus biofilms to ActivHeal hydrogel, which was used as a negative control, also resulted in small but significant reductions in viable counts following 8 h exposure. This hydrogel contains propylene glycol as a preservative, which has been reported to exhibit bacteriostatic activity, 42 and could therefore account for the reductions in S. aureus biofilm counts following long-term exposure.
In summary, we have demonstrated putative antimicrobial synergy between polyphosphate and ionic silver. Hydrogels supplemented with combinations of polyphosphate and ionic silver exhibited rapidly manifested and significantly elevated anti-biofilm activity. With respect to effects on host tissues, polyphosphates have previously been shown to accelerate clot formation with reduced susceptibility to fibrinolysis 43 and to lower elastase and collagenase activity. 44 As such, polyphosphates may contribute to wound healing, and when combined with silver may reduce microbial bioburdens through potentiated antimicrobial activity.
